Genus FY profit nudges up but revenue slips on lower bovine volumes
FTSE 250 animal genetics company Genus posted an increase in pre-tax profit for the year to the end of June despite a small drop in revenue.
FTSE 250
20,359.21
17:14 13/11/24
FTSE 350
4,434.70
17:14 13/11/24
FTSE All-Share
4,392.88
16:44 13/11/24
Genus
1,776.00p
16:40 13/11/24
Pharmaceuticals & Biotechnology
19,607.01
17:14 13/11/24
Adjusted pre-tax profit was up 7% to £49.7m, driven by strong performances in Genus PIC and Genus Asia, particularly China.
Statutory pre-tax profit was 5% higher at £60.9m, which included a pension-related exceptional credit of £44.2m and a reduction in the value of biological assets.
However, revenue at the group was down 3% to £388.3m on the back of lower bovine volumes in tough dairy markets and lower porcine by-product and up-front sales.
Chief executive Karim Bitar said: “Genus performed well overall in 2016 with another year of double digit constant currency profit growth and substantial strategic progress in our R&D endeavours in addition to growth in key markets such as China.
"To pursue our long-term growth objectives, we plan to increase R&D investment in FY17 and therefore expect broadly stable constant currency results, however exchange rates should provide a benefit to the reported numbers. Overall we expect to perform in line with market expectations. We are confident in the future of the business and are proposing a 10% increase in the dividend."
The company proposed a total dividend for the year of 21.4p per share, up from 19.5p in 2015.